Biosentry

Company profile

Biosentry company profile

Biosentry is an R&D company building physics informed, mechanistic AI for cardiac safety in drug development. Our first go to market platform focuses on cardiac safety and separates acute ion channel block from trafficking disruption, a time delayed mechanism that may be missed by acute assays. We deliver auditable outputs with explicit assumptions and traceability, designed for regulated R&D and nonclinical decision support. Deployment is on premises so proprietary compound data and IP remain inside your infrastructure.